Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables Refunds
Ratios

Beauty Health (SKIN) Accumulated Depreciation & Amortization (2020 - 2025)

Beauty Health (SKIN) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization changed N/A to $2.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.0 million, a N/A change, with the full-year FY2023 number at -$8.3 million, up 37.34% from a year prior.
  • Accumulated Depreciation & Amortization was $2.0 million for Q3 2025 at Beauty Health, up from -$1.4 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.0 million in Q3 2025 to a low of -$13.5 million in Q3 2022.
  • A 5-year average of -$7.8 million and a median of -$8.3 million in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: plummeted 34.68% in 2021, then soared 37.34% in 2023.
  • Beauty Health's Accumulated Depreciation & Amortization stood at -$10.8 million in 2021, then decreased by 22.65% to -$13.3 million in 2022, then skyrocketed by 37.34% to -$8.3 million in 2023, then soared by 83.35% to -$1.4 million in 2024, then surged by 245.96% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Accumulated Depreciation & Amortization are $2.0 million (Q3 2025), -$1.4 million (Q2 2024), and -$6.1 million (Q1 2024).